108 related articles for article (PubMed ID: 3265315)
1. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens.
Pinchouk VG; Sidorenko SP; Gluzman DF; Vetrova EP; Berdova AG; Schlapatskaya LN
Anticancer Res; 1988; 8(6):1377-80. PubMed ID: 3265315
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
3. [IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen].
Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN; Evsev'eva AI
Eksp Onkol; 1988; 10(3):42-4. PubMed ID: 2457482
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies to RPMI-1788 lymphoblastoid line cells].
Pinchuk VG; Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN
Eksp Onkol; 1986; 8(6):41-6. PubMed ID: 3026773
[TBL] [Abstract][Full Text] [Related]
6. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
7. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
8. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299
[TBL] [Abstract][Full Text] [Related]
9. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
10. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
Al-Katib A; Wang CY; Koziner B
Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells.
Fukukawa T; Matsuzaki H; Haruta Y; Hara H; Seon BK
Exp Hematol; 1986 Oct; 14(9):850-5. PubMed ID: 3489635
[TBL] [Abstract][Full Text] [Related]
12. Identification of an early activation antigen (Bac-1) on human B cells.
Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
Sidorenko SP; Clark EA
J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
15. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
16. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
18. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies of the IPO series in studying and diagnosing malignant lymphoproliferative diseases].
Sidorenko SP; Vetrova EP; Iurchenko OV; Shlapatskaia LN; Berdova AG; Elenskaia AM; Bal'shin MD; Gluzman DF
Gematol Transfuziol; 1990 Apr; 35(4):19-22. PubMed ID: 2373343
[TBL] [Abstract][Full Text] [Related]
20. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
